/PRNewswire/ Doseology Sciences Inc.. (CSE: MOOD) (FSE: VU7) ("Doseology" or the "Company"), a life sciences company focused on mental health and wellness,.
Toronto, Ontario (Newsfile Corp. - December 15, 2021) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced its market statistics for the month of November 2021, which was highlighted
Doseology Raises $4,451,568 and Files Preliminary Non-Offering Prospectus to Go Public
VERNON, B.C., May 13, 2021 /PRNewswire/
Doseology Sciences Inc
. ( Doseology or the Company ), a mental health and wellness company focused in the functional mushroom and psychedelic sectors, is pleased to announce the ?ling of a preliminary non-offering long form prospectus (the Prospectus ) with the Alberta and British Columbia Securities Commission..
Dan Vice, Co-founder, commented: We are thrilled to have ?led our preliminary prospectus. The bene?ts of going-public as a means to raise signi?cant capital will allow us to fund and build a library of intellectual property from scienti?c research and development for psilocybin, psilocin and functional mushrooms. Mr. Vice further commented The additional capital will also allow us to roll out our psychedelic-assisted therapy clinics starting in Portland, Oregon for the treatment